Christopher W Dukes

3PUBLICATIONS
22CO-AUTHORS
MechanobiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.

Joseph Markowitz, Michael Shamblott, Andrew S Brohl

|Jan 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.

Christopher W Dukes, Marine Potez, Jeffrey Lancet

|Jun 28, 2023
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients.

Anna Giuliano, Barbara Kuter, Shari Pilon-Thomas

Pageof 1